The Medicare Rights Center reports that President Trump’s executive order on prescription drug pricing supports key drug ...

The country’s pharmaceuticals market grew by 8.4 per cent during financial year 2024-25 on the back of major therapies ...

Not one but two new studies published today have linked GLP-1 drugs like Ozempic to a decreased risk of developing dementia. There is currently no cure for Alzheimer’s, which affects an ...

SGLT2 inhibitors are medications designed to help manage blood sugar in people living with type 2 diabetes. Learn more about the different types, as well as the benefits and side effects. Sodium ...

BOSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing a range of next ...

At the American College of Cardiology’s 74th Annual Scientific Session in Chicago, further results and analyses were presented from the SUMMIT trial. SUMMIT was the first trial in patients with heart ...

Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus ® (oral semaglutide) significantly reduced the ...

UCLA scientists have developed a molecule, PP405, that may reverse hair loss by reactivating dormant follicles. Early trials show promising results, and more testing is underway, with FDA approval ...

Almost 38 out of the total formulations for which the prices fixed in the meeting were of various formulations and strengths comprising empagliflozin, the anti-diabetes drug for which Boehringer ...

A team of researchers from McMaster University has identified a new molecule – lariocidin – that can challenge some of the most drug-resistant bacteria on Earth. The discovery responds to a critical ...